Table 2 Demographic characteristics, risk factors and reported symptoms at onset in the retrospective population group

Mean age (years) ± standard deviation (SD)

5.6 ± 5.2

Sex

 M

118

52.2

 F

108

47.8

RISK FACTORS/ANAMNESTIC DATA

 History of Contact

121

53.5

 Travel in high risk countries

11

4.9

 Born in high risk country

29

12.8

 Parents origin’s from high risk countries

136

60.2

 Immunosuppression or immunosuppressive therapy

4

1.8

Antibiotic therapy

92

40.7

 - With no benefit

91

98.9

 Positive Quantiferon (analyzed before hospitalization)

37

16.4

 Positive Mantoux (analyzed before hospitalization)

94

41.6

SIGNS/SYMPTOMS

 Cough

112

49.6

 Cough lasting ≥ 10 days

49

21.7

 Fever

104

46.0

 Fever lasting ≥ 10 days

44

19.4

 Lymphadenopathy

36

15.9

 Asthenia

35

15.5

 Weight loss

22

9.7

 Chest pain

16

7.1

 Hemoptysis

6

2.6

 Night sweats

4

1.8

DIAGNOSTIC TOOLS

 Mantoux: positive ( +) (≥ 5 mm)

210

92.9

 QTF + 

216

95.6

 Culture + 

86

42.2

 PCR + 

79

37.6

 Bacterioscopic + 

40

18.0